Evidence map›Paper›PMID 34907248›Full record

ArticleScientific reports2021

Pharmacokinetics and central accumulation of delta-9-tetrahydrocannabinol (THC) and its bioactive metabolites are influenced by route of administration and sex in rats.

Samantha L Baglot, Catherine Hume, Gavin N Petrie, Robert J Aukema, Savannah H M Lightfoot, Laine M Grace, Ruokun Zhou, Linda Parker, Jong M Rho, Stephanie L Borgland and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Sex-specific role of microglia in ΔNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  4. Article
  5. Cannabinoid neuropharmacology across the lifespan: how aging recalibrates risk and benefit.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models.Current topics in behavioral neurosciences · 2026
    Review
  14. Cannabis produces acute hyperphagia in humans and rodents via increased reward valuation for, and motivation to, acquire food.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. Article
  16. Timing matters: modeling the effects of gestational cannabis exposure on social behavior and microglia in the developing amygdala.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  17. Article
  18. Article
  19. Review
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Samantha L BaglotHotchkiss Brain Institute | Mathison Centre for Mental Health Research & Education, University of Calgary, Calgary, AB, Canada. samantha.baglot@ucalgary.ca.
Catherine HumeHotchkiss Brain Institute | Mathison Centre for Mental Health Research & Education, University of Calgary, Calgary, AB, Canada.
Gavin N PetrieHotchkiss Brain Institute | Mathison Centre for Mental Health Research & Education, University of Calgary, Calgary, AB, Canada.
Robert J AukemaHotchkiss Brain Institute | Mathison Centre for Mental Health Research & Education, University of Calgary, Calgary, AB, Canada.
Savannah H M LightfootHotchkiss Brain Institute | Mathison Centre for Mental Health Research & Education, University of Calgary, Calgary, AB, Canada.
Laine M GraceHotchkiss Brain Institute | Mathison Centre for Mental Health Research & Education, University of Calgary, Calgary, AB, Canada.
Ruokun ZhouSouthern Alberta Mass Spectrometry (SAMS) Facility, University of Calgary, Calgary, AB, Canada.
Linda ParkerDepartment of Psychology and Collaborative Neuroscience Program, University of Guelph, Guelph, Canada.
Jong M RhoDepartments of Neurosciences and Pediatrics, University of California San Diego, and Rady Children's Hospital San Diego, San Diego, CA, USA.
Stephanie L BorglandHotchkiss Brain Institute | Mathison Centre for Mental Health Research & Education, University of Calgary, Calgary, AB, Canada.
Ryan J McLaughlinDepartment of Integrative Physiology and Neuroscience, Washington State University, Pullman, WA, USA.
Laurent BrechenmacherSouthern Alberta Mass Spectrometry (SAMS) Facility, University of Calgary, Calgary, AB, Canada.
Matthew N HillHotchkiss Brain Institute | Mathison Centre for Mental Health Research & Education, University of Calgary, Calgary, AB, Canada. mnhill@ucalgary.ca.
University of Calgary · CARady Children's Hospital-San Diego · USUniversity of Guelph · CAWashington State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Up to a third of North Americans report using cannabis in the prior month, most commonly through inhalation. Animal models that reflect human consumption are critical to study the impact of cannabis on brain and behaviour. Most animal studies to date utilize injection of delta-9-tetrahydrocannabinol (THC; primary psychoactive component of cannabis). THC injections produce markedly different physiological and behavioural effects than inhalation, likely due to distinctive pharmacokinetics. The current study directly examined if administration route (injection versus inhalation) alters metabolism and central accumulation of THC and metabolites over time. Adult male and female Sprague-Dawley rats received either an intraperitoneal injection or a 15-min session of inhaled exposure to THC. Blood and brains were collected at 15, 30, 60, 90 and 240-min post-exposure for analysis of THC and metabolites. Despite achieving comparable peak blood THC concentrations in both groups, our results indicate higher initial brain THC concentration following inhalation, whereas injection resulted in dramatically higher 11-OH-THC concentration, a potent THC metabolite, in blood and brain that increased over time. Our results provide evidence of different pharmacokinetic profiles following inhalation versus injection. Accordingly, administration route should be considered during data interpretation, and translational animal work should strongly consider using inhalation models.

Indexed as

DronabinolSex CharacteristicsAdministration, InhalationAnimalsFemaleInjections, IntraperitonealMaleRatsRats, Sprague-DawleyDronabinol

Identifiers

PMID34907248
PMCPMC8671514
OpenAlexW4200223554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.